Preoperative Bevacizumab in Combination With Paclitaxel and Carboplatin in Surgically Resectable Non-Small Cell Lung Cancer

被引：3
|
作者：
Bertino, Erin [1 ]
Villalona-Calero, Miguel A. [1 ]
Ross, Patrick [2 ]
Grever, Michael [3 ]
Otterson, Gregory A. [3 ]
机构：
[1] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
来源：
ANNALS OF THORACIC SURGERY | 2011年 / 91卷 / 02期
关键词：
TRIAL; SURGERY; CHEMOTHERAPY;
D O I：
10.1016/j.athoracsur.2010.07.047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：640 / 640
页数：1
相关论文
共 50 条
  • [31] Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung Cancer
    Bagley, Stephen J.
    Talento, Suzanna
    Mitra, Nandita
    Meropol, Neal J.
    Cohen, Roger B.
    Langer, Corey J.
    Vachani, Anil
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (05): : 469 - 477
  • [32] Cost-Effectiveness of the Addition of Bevacizumab to First-Line Chemotherapy With Carboplatin and Paclitaxel in Patients With Non-Small Cell Lung Cancer
    Parody-Rua, Elizabeth
    Augusto Guevara-Cuellar, Cesar
    VALUE IN HEALTH REGIONAL ISSUES, 2020, 23 : 93 - 98
  • [33] Carboplatin and weekly paclitaxel in non-small cell lung cancer patients unfit for or pretreated with chemotherapy
    Numico, G
    Colantonio, I
    Gasco, M
    Bertelli, G
    Garrone, O
    Occelli, M
    Fea, E
    Di Costanzo, G
    Granetto, C
    Heouaine, A
    Russi, E
    Merlano, M
    ANTICANCER RESEARCH, 2005, 25 (3C) : 2555 - 2559
  • [34] Comparison of gemcitabine/carboplatin versus paclitaxel/cisplatin for the management of non-small cell lung cancer
    Wang, Wei
    Li, Wenli
    Dai, Lili
    Zhao, Lei
    Qu, Kaixin
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (08) : 1763 - 1770
  • [35] Evaluation of Natriuretic Peptide in Non-small Cell Lung Cancer Patients Treated with Bevacizumab Together with Carboplatin-Paclitaxel: A Prospective Study
    Otsuka, Tomoyuki
    Nojiri, Takashi
    Minami, Seigo
    Hosoda, Hiroshi
    Kuroyama, Muneyoshi
    Hirata, Haruhiko
    Nakanishi, Kaori
    Yamamoto, Suguru
    Komuta, Kiyoshi
    Kangawa, Kenji
    Kijima, Takashi
    ANTICANCER RESEARCH, 2017, 37 (07) : 3505 - 3512
  • [36] The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer
    Dunne, Elizabeth G.
    Fick, Cameron N.
    Isbell, James M.
    Chaft, Jamie E.
    Altorki, Nasser
    Park, Bernard J.
    Spicer, Jonathan
    Forde, Patrick M.
    Gomez, Daniel
    Iyengar, Puneeth
    Harpole Jr, David H.
    Stinchcombe, Thomas E.
    Liberman, Moishe
    Bott, Matthew J.
    Adusumilli, Prasad S.
    Huang, James
    Rocco, Gaetano
    Jones, David R.
    ANNALS OF THORACIC SURGERY, 2024, 118 (01) : 119 - 129
  • [37] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Gutierrez-Sainz, Laura
    Cruz-Castellanos, Patricia
    Higuera, Oliver
    De Castro-Carpeno, Javier
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (10)
  • [38] Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer
    Nagel, Sylke
    Califano, Raffaele
    Thatcher, Nicholas
    Blackhall, Fiona
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (18) : 3265 - 3275
  • [39] Neoadjuvant immunotherapy in resectable non-small cell lung cancer at a checkpoint
    Faltermeier, Claire M.
    Lee, Jay M.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (12) : 4328 - 4335
  • [40] Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
    Nakadate, Megumi
    Yamazaki, Koichi
    Konishi, Jun
    Kinoshita, Ichiro
    Sukoh, Noriaki
    Harada, Masao
    Akie, Kenji
    Ogura, Shigeaki
    Ishida, Takashi
    Munakata, Mitsuru
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3767 - 3772
12345